Allarity Therapeutics annual ebitda
2020
2021
2022
2023
2024
Allarity Therapeutics EBITDA Growth & History (ALLR)
Allarity Therapeutics's calculated EBITDA was −$27.2M for fiscal 2024.
View full Allarity Therapeutics company overviewAllarity Therapeutics annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | −$27.2M | −$10.1M | — |
| 2023 | 2023-12-31 | −$17.1M | $17.3M | — |
| 2022 | 2022-12-31 | −$34.4M | −$8.0M | — |
| 2021 | 2021-12-31 | −$26.4M | −$18.2M | — |
| 2020 | 2020-12-31 | −$8.3M | — | — |
Allarity Therapeutics quarterly ebitda
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | −$4.1M | −$751,000 | — |
| Q1 2025 | 2025-03-31 | −$3.0M | $1.2M | — |
| Q4 2024 | 2024-12-31 | −$7.3M | −$2.4M | — |
| Q3 2024 | 2024-09-30 | −$12.3M | −$7.9M | — |
| Q2 2024 | 2024-06-30 | −$3.4M | $777,000 | — |
| Q1 2024 | 2024-03-31 | −$4.2M | −$580,000 | — |
| Q4 2023 | 2023-12-31 | −$4.9M | $1.9M | — |
| Q3 2023 | 2023-09-30 | −$4.4M | $134,000 | — |
| Q2 2023 | 2023-06-30 | −$4.1M | $671,000 | — |
| Q1 2023 | 2023-03-31 | −$3.7M | $14.6M | — |
| Q4 2022 | 2022-12-31 | −$6.7M | $9.0M | — |
| Q3 2022 | 2022-09-30 | −$4.6M | −$614,000 | — |
| Q2 2022 | 2022-06-30 | −$4.8M | −$439,000 | — |
| Q1 2022 | 2022-03-31 | −$18.3M | −$15.9M | — |
| Q4 2021 | 2021-12-31 | −$15.7M | — | — |
| Q3 2021 | 2021-09-30 | −$3.9M | — | — |
| Q2 2021 | 2021-06-30 | −$4.4M | — | — |
| Q1 2021 | 2021-03-31 | −$2.4M | — | — |
Allarity Therapeutics ebitda trends
Across the available reported history, Allarity Therapeutics's ebitda decreased from −$17.1M to −$27.2M, a change of −$10.1M. The latest reported quarter, Q2 2025, shows −$4.1M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Allarity Therapeutics filings at SEC.gov ↗